Christopher Wale

2.4k total citations · 2 hit papers
9 papers, 1.8k citations indexed

About

Christopher Wale is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Wale has authored 9 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Wale's work include Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (3 papers). Christopher Wale is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (3 papers). Christopher Wale collaborates with scholars based in United Kingdom, United States and Australia. Christopher Wale's co-authors include Jack Cuzick, Anthony Howell, Aman U. Buzdar, Mitch Dowsett, Janine Salter, John Forbes, Emma M. Quinn, Lila Zabaglo, Sílvia Pineda and Ian O. Ellis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Christopher Wale

9 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

2010 546 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

2011 540 citations Jack Cuzick, Mitch Dowsett et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Wale United Kingdom	9	1.2k	987	553	300	291	9	1.8k
Javaid Iqbal Canada	15	782 0.7×	1.1k 1.1×	430 0.8×	206 0.7×	381 1.3×	23	1.8k
C.-M. Rudenstam Sweden	18	746 0.6×	1.2k 1.2×	437 0.8×	304 1.0×	248 0.9×	28	1.7k
Hans-Jörg Senn Switzerland	8	1.0k 0.9×	873 0.9×	312 0.6×	182 0.6×	361 1.2×	9	1.6k
Irma Fredriksson Sweden	22	805 0.7×	946 1.0×	231 0.4×	221 0.7×	263 0.9×	64	1.5k
Erin Hofstatter United States	21	612 0.5×	812 0.8×	463 0.8×	252 0.8×	203 0.7×	60	1.9k
J. Cuzick United Kingdom	15	812 0.7×	1.2k 1.2×	695 1.3×	314 1.0×	375 1.3×	40	2.1k
Dong‐Young Noh South Korea	27	791 0.7×	788 0.8×	383 0.7×	211 0.7×	585 2.0×	52	1.8k
Maira Caleffi Brazil	24	506 0.4×	907 0.9×	483 0.9×	109 0.4×	340 1.2×	79	1.8k
Jean Robert Canada	13	1.2k 1.0×	1.2k 1.2×	207 0.4×	320 1.1×	575 2.0×	14	2.1k
Ashley Stuckey United States	25	454 0.4×	648 0.7×	384 0.7×	211 0.7×	343 1.2×	85	1.9k

Countries citing papers authored by Christopher Wale

Since Specialization

Citations

This map shows the geographic impact of Christopher Wale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wale more than expected).

Fields of papers citing papers by Christopher Wale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Wale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wale. The network helps show where Christopher Wale may publish in the future.

Co-authorship network of co-authors of Christopher Wale

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Wale. A scholar is included among the top collaborators of Christopher Wale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Wale. Christopher Wale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Moss, Sue, Christopher Wale, Robert A. Smith, et al.. (2015). Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. The Lancet Oncology. 16(9). 1123–1132. 131 indexed citations

Cuzick, Jack, Mitch Dowsett, Sílvia Pineda, et al.. (2011). Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer. Journal of Clinical Oncology. 29(32). 4273–4278. 540 indexed citations breakdown →

Dowsett, Mitch, Jack Cuzick, Christopher Wale, et al.. (2010). Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study. Journal of Clinical Oncology. 28(11). 1829–1834. 546 indexed citations breakdown →

Tang, Grace H., J. Cuzick, Christopher Wale, et al.. (2010). Recurrence risk of node-negative and ER-positive early-stage breast cancer patients by combining recurrence score, pathologic, and clinical information: A meta-analysis approach.. Journal of Clinical Oncology. 28(15_suppl). 509–509. 11 indexed citations

Cuzick, Jack, Mitch Dowsett, Christopher Wale, et al.. (2009). Prognostic Value of a Combined ER, PgR, Ki67, HER2 Immunohistochemical (IHC4) Score and Comparison with the GHI Recurrence Score – Results from TransATAC.. Cancer Research. 69(24_Supplement). 74–74. 54 indexed citations

Buzdar, Aman U., Anthony Howell, Jack Cuzick, et al.. (2006). Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. The Lancet Oncology. 7(8). 633–643. 355 indexed citations

Doyle, Pat, Valerie Beral, Beverley Botting, & Christopher Wale. (1991). Congenital malformations in twins in England and Wales.. Journal of Epidemiology & Community Health. 45(1). 43–48. 95 indexed citations

Beresford, S A, et al.. (1977). Why do women consult doctors? Social factors and the use of the general practitioner.. Journal of Epidemiology & Community Health. 31(4). 220–226. 8 indexed citations

Morrell, D C & Christopher Wale. (1976). Symptoms perceived and recorded by patients.. PubMed. 26(167). 398–403. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact